Metastatic Non-Small Cell Lung Carcinoma
5 clinical trials · Condition
◉ Watch Metastatic Non-Small Cell Lung Carcinoma
| Record | Firm | Date |
|---|---|---|
| Development of a Cell Free DNA Assay as a Biomarker for Predicting Early Non-response to Therapy in Metastatic Cancer (NCT03892096) | Cadex Genomics | 2019-03-01 |
| Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease (NCT03808337) | Memorial Sloan Kettering Cancer Center | 2019-01-16 |
| Pembrolizumab for Metastatic NSCLC Patients Expressing PD-L1 Who Have Their Own PDX (NCT03134456) | Samsung Medical Center | 2018-05-14 |
| Perfusion-Induced Hyperthermia for Metastatic Carcinoma (NCT02409108) | Jonathan Kiev | 2015-07-01 |
| The Jules Bordet Institute Molecular Profiling Program Feasibility Trial (NCT01932489) | Jules Bordet Institute | 2013-12-01 |
Track Metastatic Non-Small Cell Lung Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.